Charles River Laboratories | CRL - Stock



Charles River Laboratories reported $279.55M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Agilent USD 1.01B 23M Jul/2025
Align Technology USD 246.57M 7.72M Mar/2025
Bio-Rad Laboratories USD 798.8M 8.7M Jun/2025
Bruker USD 1.22B 101.8M Jun/2025
Cardinal Health USD 16.83B 673M Jun/2025
Charles River Laboratories USD 279.55M 10.61M Jun/2025
Cigna USD 5.97B 791M Jun/2025
CVS Health USD 17.45B 62M Jun/2025
Danaher USD 2.69B 157M Jun/2025
Dentsply International USD 675M 63M Jun/2025
Elevance Health 0 0 Dec/2024
Galapagos EUR 38.52M 12.67M Mar/2025
Hologic USD 713.7M 3M Jun/2025
Illumina USD 575M 38M Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
Laboratory Of America USD 508.1M 19.8M Jun/2025
Lonza CHF 1.73B 13M Dec/2024
McKesson USD 25.06B 2.06B Jun/2025
Merck EUR 4.47B 45M Jun/2025
Mettler Toledo International USD 388.08M 29.3M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Quest Diagnostics USD 187M 2M Jun/2025
Revvity USD 388.47M 7.16M Jun/2025
Thermo Fisher Scientific USD 5.56B 335M Jun/2025
United Therapeutics USD 169.2M 3.8M Jun/2025
UnitedHealth 280M 280M Dec/2023
Waters USD 540.75M 29.26M Jun/2025
West Pharmaceutical Services USD 421.1M 32.4M Jun/2025